ALLMedicine™ Yellow Fever Center

Feb 18th, 2021 - The Eliminate Yellow fever Epidemics (EYE) strategy was launched in 2017 in response to the resurgence of yellow fever in Africa and the Americas. The strategy relies on several vaccination activities, including preventive mass vaccination campaig...

Feb 16th, 2021 - The mosquito Aedes aegypti is a major vector for the arthropod-borne viruses (arboviruses) chikungunya, dengue, yellow fever and Zika viruses. Vector immune responses pose a major barrier to arboviral transmission, and transgenic insects with alte...

Feb 7th, 2021 - Sickle Cell Disease (SCD) children are frequent travellers to countries where Yellow Fever (YF) is endemic, but there are no data regarding the safety and immunogenicity of the vaccine in such children treated with hydroxyurea (HU). The main objec...

Feb 5th, 2021 - Aedes aegypti is a highly competent vector in the transmission of arboviruses, such as chikungunya, dengue, Zika and yellow fever, and causes single and coinfections in the populations of tropical countries. The infection rate, viral abundance, ve...

Feb 5th, 2021 - Yellow fever virus (YFV) live attenuated vaccine can, in rare cases, cause life-threatening disease, typically in patients with no previous history of severe viral illness. Autosomal recessive (AR) complete IFNAR1 deficiency was reported in one 12...

Nov 13th, 2018 - Yellow fever is a mosquito-borne viral illness found in tropical and subtropical areas in South America and Africa. Transmission is primarily via Aedes and Haemagogus species of mosquito.

May 3rd, 2018 - Information on Yellow Fever. Provided by the U.S. Centers for Disease Control and Prevention.

Jul 30th, 2010 - This report updates CDC's recommendations for using yellow fever (YF) vaccine (CDC. Yellow fever vaccine: recommendations of the Advisory Committee on Immunizations Practices: MMWR 2002;51[No. RR-17]). Since the previous YF vaccine recommendations...

Feb 18th, 2021 - The Eliminate Yellow fever Epidemics (EYE) strategy was launched in 2017 in response to the resurgence of yellow fever in Africa and the Americas. The strategy relies on several vaccination activities, including preventive mass vaccination campaig...

Feb 16th, 2021 - The mosquito Aedes aegypti is a major vector for the arthropod-borne viruses (arboviruses) chikungunya, dengue, yellow fever and Zika viruses. Vector immune responses pose a major barrier to arboviral transmission, and transgenic insects with alte...

Feb 7th, 2021 - Sickle Cell Disease (SCD) children are frequent travellers to countries where Yellow Fever (YF) is endemic, but there are no data regarding the safety and immunogenicity of the vaccine in such children treated with hydroxyurea (HU). The main objec...

Feb 5th, 2021 - Aedes aegypti is a highly competent vector in the transmission of arboviruses, such as chikungunya, dengue, Zika and yellow fever, and causes single and coinfections in the populations of tropical countries. The infection rate, viral abundance, ve...

Feb 5th, 2021 - Yellow fever virus (YFV) live attenuated vaccine can, in rare cases, cause life-threatening disease, typically in patients with no previous history of severe viral illness. Autosomal recessive (AR) complete IFNAR1 deficiency was reported in one 12...

Jan 10th, 2019 - Leading cancer expert, Professor Martin Gore, 67, died suddenly yesterday following a routine vaccination for yellow fever.     Prof Martin Gore The Royal Marsden Trust (RMT) has set up a hotline for patients of Prof Gore and anyone with clinical ...

Dec 18th, 2018

Dec 18th, 2018

Nov 13th, 2018 - Yellow fever is a mosquito-borne viral illness found in tropical and subtropical areas in South America and Africa. Transmission is primarily via Aedes and Haemagogus species of mosquito.

Nov 5th, 2018